• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Researchers pinpoint bacteria that may trigger MS 20 May 2025
MS News MS Trials
Researchers pinpoint bacteria that may trigger MS
Tolebrutinib lowers the risk of disability progression in non-relapsing secondary MS 20 May 2025
MS News MS Trials
Tolebrutinib lowers the risk of disability progression in non-relapsing secondary MS
How genetic changes accumulate in the brain in MS – Insights from tissue studies 23 April 2025
MS News MS Trials
How genetic changes accumulate in the brain in MS – Insights from tissue studies
Online fatigue intervention program shows promising results for people with MS 23 April 2025
MS News MS Trials
Online fatigue intervention program shows promising results for people with MS
Evobrutinib does not outperform standard treatment in phase 3 trial 23 April 2025
MS News MS Trials
Evobrutinib does not outperform standard treatment in phase 3 trial
International Women’s Day – women and MS 7 March 2025
MS News MS Trials
International Women’s Day – women and MS
Have your say in prioritising our MS research and advocacy agenda 28 February 2025
MS Brainbank MS News MS Trials
Have your say in prioritising our MS research and advocacy agenda
25 February 2025
MS Brainbank MS News MS Trials
Get Ready for InforMS: Join the AMSLS Today
People with MS help shortlist drugs for repurposing in clinical trials 29 January 2025
MS Brainbank MS News MS Trials
People with MS help shortlist drugs for repurposing in clinical trials
Could drugs that target EBV treat MS? 29 January 2025
MS Brainbank MS News MS Trials
Could drugs that target EBV treat MS?
Load More
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2025 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • Enter your details

Researchers pinpoint bacteria that may trigger MS